UNIGE document Scientific Article - Review
previous document  unige:5469  next document
add to browser collection
Title

Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis

Authors
Tubiana-Hulin, Michèle
Spielmann, Marc
Roux, Christian
Campone, Mario
Zelek, Laurent
Gligorov, Joseph
show hidden authors show all authors [1 - 10]
Published in Critical Reviews in Oncology / Hematology. 2009, vol. 71, no. 1, p. 12-21
Abstract Bisphosphonates (BP) are the current standard of care for preventing malignant skeletal related-events. Recent reports have documented the relationship between osteonecrosis of the jaws (ONJ) and the use of BPs. Based on the opinion of experts, the purpose of our analysis was to summarize current knowledge, to propose therapeutic options, and to define areas of research. Identified risk factors were long-lasting exposure to BPs, intravenous nitrogen-containing BPs, and poor dental status. Three major hypotheses could explain the genesis of ONJ: excess of bone turnover inhibition, antiangiogenic effect, and local infection. Before the onset of therapy, the dental status must be controlled, and followed during treatment. Dental procedures could worsen the risk of ONJ, and indications must be well evaluated. When an ONJ occurs, the management should be adapted according to its extent. Thereby, a customization of BP therapy should be applied taking into account the aggressiveness of the underlying disease.
Keywords Bone Neoplasms/drug therapyDiphosphonates/adverse effects/therapeutic useHumansIncidenceJaw Diseases/chemically induced/diagnosis/physiopathology/therapyOsteonecrosis/chemically induced/diagnosis/physiopathology/therapy
Identifiers
PMID: 19070505
Full text
Article (Published version) (706 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Citation
(ISO format)
TUBIANA-HULIN, Michèle et al. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. In: Critical Reviews in Oncology / Hematology, 2009, vol. 71, n° 1, p. 12-21. https://archive-ouverte.unige.ch/unige:5469

205 hits

2 downloads

Update

Deposited on : 2010-03-17

Export document
Format :
Citation style :